Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Rembrandt acquisition

This article was originally published in The Tan Sheet

Executive Summary

Johnson & Johnson Personal Products company has completed its acquisition of Gillette's Rembrandt brand, the company announces Dec. 21. The acquisition was initially announced in October and represents entry into the tooth whitening category for J&J ("The Tan Sheet" Oct. 31, 2005, p. 7). The brand was sold due to FTC's competition requirements following Procter & Gamble's purchase of Gillette. J&J now has rights to all consumer and professionally dispensed Rembrandt products, including toothpastes, whitening strips, systems and mouth rinses...

You may also be interested in...



Rembrandt Reformulations, Improvements Include New Flavors

Rembrandt Oral Health is relaunching its whitening toothpastes and treatments in February with all-new packaging and specific product reformulations, Johnson & Johnson says

Rembrandt Purchase Brings Whitening Category To J&J

Johnson & Johnson gains entry into the tooth whitening segment with the purchase of Rembrandt oral care brand from Procter & Gamble's Gillette division

Pink Sheet Podcast: Woodcock To Be Acting US FDA Chief, Key Staff Depart, Political Donations Shift

Pink Sheet reporters and editor discuss President-Elect Joe Biden’s decision to name the CDER director as acting FDA commissioner and other staffing changes, as well as changes to industry trade groups’ political donations.

Topics

UsernamePublicRestriction

Register

LL1134025

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel